BTEK.L vs. SBIO.L
Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L).
BTEK.L and SBIO.L are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BTEK.L is a passively managed fund by iShares that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Oct 19, 2017. SBIO.L is a passively managed fund by Invesco that tracks the performance of the NASDAQ Biotechnology TR USD. It was launched on Nov 6, 2014. Both BTEK.L and SBIO.L are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BTEK.L or SBIO.L.
Key characteristics
| BTEK.L | SBIO.L | |
|---|---|---|
| YTD Return | 0.85% | 0.38% |
| 1Y Return | 4.80% | 7.34% |
| 3Y Return (Ann) | 1.50% | -2.20% |
| 5Y Return (Ann) | 6.52% | 6.47% |
| Sharpe Ratio | 0.28 | 0.38 |
| Daily Std Dev | 14.90% | 16.23% |
| Max Drawdown | -30.86% | -39.44% |
| Current Drawdown | -10.77% | -17.97% |
Correlation
The correlation between BTEK.L and SBIO.L is 0.95, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
BTEK.L vs. SBIO.L - Performance Comparison
In the year-to-date period, BTEK.L achieves a 0.85% return, which is significantly higher than SBIO.L's 0.38% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BTEK.L vs. SBIO.L - Expense Ratio Comparison
BTEK.L has a 0.35% expense ratio, which is lower than SBIO.L's 0.40% expense ratio.
Risk-Adjusted Performance
BTEK.L vs. SBIO.L - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) and Invesco Nasdaq Biotech UCITS ETF (SBIO.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BTEK.L vs. SBIO.L - Dividend Comparison
Neither BTEK.L nor SBIO.L has paid dividends to shareholders.
Drawdowns
BTEK.L vs. SBIO.L - Drawdown Comparison
The maximum BTEK.L drawdown since its inception was -30.86%, smaller than the maximum SBIO.L drawdown of -39.44%. Use the drawdown chart below to compare losses from any high point for BTEK.L and SBIO.L. For additional features, visit the drawdowns tool.
Volatility
BTEK.L vs. SBIO.L - Volatility Comparison
The current volatility for iShares Nasdaq US Biotechnology UCITS ETF (BTEK.L) is 4.69%, while Invesco Nasdaq Biotech UCITS ETF (SBIO.L) has a volatility of 5.14%. This indicates that BTEK.L experiences smaller price fluctuations and is considered to be less risky than SBIO.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.